MREO
Mereo BioPharma
MREO
MREO
61 hedge funds and large institutions have $46.2M invested in Mereo BioPharma in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $49.4M → $46.2M (-$3.27M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
61
Holding in Top 10
–
Calls
$93K
Puts
$87K
Top Buyers
| 1 | +$1.4M | |
| 2 | +$1.19M | |
| 3 | +$99.6K | |
| 4 |
Barclays
London,
United Kingdom
|
+$95.4K |
| 5 |
6CM
683 Capital Management
New York
|
+$93.8K |
Top Sellers
| 1 | -$8.46M | |
| 2 | -$1.43M | |
| 3 | -$565K | |
| 4 |
Morgan Stanley
New York
|
-$91.2K |
| 5 |
CHAM
Clear Harbor Asset Management
Stamford,
Connecticut
|
-$45.8K |